Category: Forbes

Why HeartFlow’s Data From This Weekend Don’t Change Anything

The $1.5 billion health-tech startup HeartFlow has a noninvasive test for heart disease based on machine learning analysis of CT scans. Two new studies are unlikely to win over its critics.

Brain Structure And Genetics May Influence Our Bodyweight More Than We Know, Suggests New Study

Brains, behavior and bodyweight are linked via genetics in ways we’re only starting to uncover, according to a new study that pulled data from an expansive brain mapping initiative.

NIH Comes Out Swinging On Opioid Abuse With Anticipated $40.4 Million To Research Chronic Pain

In keeping with its daunting pursuit of curbing the nation’s opioid crisis, the NIH announced today it has launched the Acute to Chronic Pain Signatures (A2CPS) program to investigate the biological characteristics underlying the transition in some peo…

Judge Dismisses GOP Effort To Block Nebraska’s Medicaid Expansion Ballot Measure

A judge dismissed an effort to block that Nebraska’s Medicaid expansion via ballot initiative, clearing the way for voters to decide whether to increase access to healthcare coverage under the Affordable Care Act.

Doctors Would Like Trump To Reduce Paperwork Without Cutting Their Pay

About 150 medical groups praised a Trump administration effort to ease “documentation requirements” but worry simplifying billing codes too much could cut doctor pay.

You May Start Seeing Drug Prices In Ads, But Will You Understand The Point?

The newly passed Senate amendment requiring drug companies to disclose the prices of their products in direct-to-consumer advertising is raising a lot of questions.

Oprah’s Pizza Ambition Could Spur Shares of Kraft Heinz

Media mogul Oprah Winfrey has moved past grocery store soups and side dishes, now she’s selling one of America’s favorite indulgences pizza. With people eating healthier foods, a frozen fan favorite may be just the thing to gain a larger share of consu…

An Unwarranted Attack On Rare Disease Research

Hearing a parent agonize over the plight of their child who suffers from a rare disease is heart wrenching. For these families, research into rare disease drugs hasn’t come close to “reaching an extreme”.

Pittsburgh’s Hired Guns Move In On Philadelphia’s Turf As Opioid Lawyers Jostle For Power

A heavyweight is trying to elbow its way into a leadership role in Pennsylvania lawsuits against the opioid industry.

Death Rates From Heart Disease And Stroke Could Be Significantly Less With These Drugs, Study Says

Death rates from heart disease and stroke could be significantly lowered by prescribing statins with blood pressure-lowering drugs, a new study says.